The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019 to 2032.
Overcoming the short-term consequences that COVID-19 pandemic has had on the interventional oncology devices, the market has begun to see recovery toward prepandemic levels.
Which procedure types were impacted the most by COVID-19?
What will recovery look like for different procedure categories over the forecast period?
The ablation device market is dominated by microwave ablation; however, new technologies are increasingly being used.
How has the adoption of cryoablation changed the market dynamics in the microwave and RF ablation device segments?
What are the strategies employed by key competitors to position themselves in this market, and what challenges do they face?
Which major clinical trials are being conducted, and how will they impact the interventional oncology device market?
Ablation therapy procedures will continue to grow for the liver, kidney, and lung cancer indications, while novel indications such as prostate and pancreatic cancer represent new opportunities for growth.
What are the advantages and disadvantages of each type of ablation device offered by competitors, and how do these differences affect adoption for different indications?
What are the major demographic, economic, and local trend differences across Europe that impact the adoption of these devices?
How will growth vary across different ablation device categories?
Newer embolization technologies are seeing increasing adoption.
How will the market growth vary across different embolization device categories?
What is the adoption outlook for different embolization devices, and what factors will affect the penetration of these technologies over the forecast period?
What impact will clinical guidance have on the adoption of newer technologies in the embolization device market?
How will the adoption of DEBs and radioembolization spheres be affected by recent clinical trials?
- Interventional Oncology Devices - Market Insights - Europe
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Interventional Oncology Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Interventional Oncology Procedures, by Procedure Type, Europe, 2019u20132032
- Interventional Oncology Procedures, by Indication, Europe, 2019u20132032
- Interventional Oncology Procedures, by Country, Europe, 2019u20132032
- Interventional Oncology Device Market, by Product Type, Europe (USD and EUR), 2019u20132032
- Interventional Oncology Device Market Growth, by Product Type, Europe, 2020u20132032
- Interventional Oncology Device Market, by Country, Europe (USD), 2019u20132032
- Interventional Oncology Device Market, by Country, Europe (EUR and GBP), 2019u20132032
- Interventional Oncology Device Market Growth, by Country, Europe, 2020u20132032
- Market Shares
- Competitive Insights
- Market Developments
- Ablation Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Ablation Procedures, by Indication, Europe, 2019u20132032
- Ablation Procedures, by Product Type, Europe, 2019u20132032
- Ablation Procedures, by Country, Europe, 2019u20132032
- Primary Liver Cancer Ablation Procedures, by Product Type, Europe, 2019u20132032
- Primary Liver Cancer Ablation Procedures, by Country, Europe, 2019u20132032
- Secondary Liver Cancer Ablation Procedures, by Product Type, Europe, 2019u20132032
- Secondary Liver Cancer Ablation Procedures, by Country, Europe, 2019u20132032
- Kidney Cancer Ablation Procedures, by Product Type, Europe, 2019u20132032
- Kidney Cancer Ablation Procedures, by Country, Europe, 2019u20132032
- Lung Cancer Ablation Procedures, by Product Type, Europe, 2019u20132032
- Lung Cancer Ablation Procedures, by Country, Europe, 2019u20132032
- Ablation Device Market, by Product Type, Europe (USD), 2019u20132032
- Ablation Device Market, by Product Type, Europe (EUR), 2019u20132032
- Ablation Device Market Growth, by Product Type, Europe, 2020u20132032
- Ablation Device Market, by Country, Europe (USD), 2019u20132032
- Ablation Device Market, by Country, Europe (EUR and GBP), 2019u20132032
- Ablation Device Market Growth, by Country, Europe, 2020u20132032
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Irreversible Electroporation Ablation Devices
- Market Shares
- Competitive Insights
- Embolization Device Market
- Accessory Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Accessory Device Market, by Product Type, Europe (USD), 2019u20132032
- Accessory Device Market, by Product Type, Europe (EUR), 2019u20132032
- Accessory Device Market Growth, by Product Type, Europe, 2020u20132032
- Accessory Device Market, by Country, Europe (USD), 2019u20132032
- Accessory Device Market, by Country, Europe (EUR and GBP), 2019u20132032
- Accessory Device Market Growth, by Country, Europe, 2020u20132032
- Guide Catheter
- Microcatheter
- Angiography Catheter
- Guidewire
- Sheath
- Market Shares
- Competitive Insights
- Appendix
Yukta Munjal
Yukta Munjal is an associate analyst on the Cardiovascular Medtech Insights team at Clarivate, specializing in the peripheral vascular device market. Yukta holds a Bachelor’s degree in Pharmaceutical Sciences from Ram-Eesh Institute of Vocational and Technical Education, Greater Noida and M.Pharm in Pharmaceutical Analysis from Delhi Pharmaceutical Sciences and Research University, New Delhi.